For persistent digestive issues, the GI timeline guides provide realistic expectations for how long these adjustments typically take
Consistent use on the same day each week ensures effective weight loss and better blood sugar control
Long-term study results are currently limited, but the following must be considered for shaping the clinical algorithm in GLP-1 RA prescribing: proper indication, the characteristics of the prescribed drug, the patient's psychiatric and somatic history, sociodemographic factors, patient expectations, and especially monitoring of response to rapid weight loss (Figure 1)
Comparative Efficacy: Weight Loss Outcomes (SURMOUNT vs STEP) There are no published head-to-head clinical trials comparing semaglutide and tirzepatide directly
Prescribers and patients should verify current regulatory status before initiating or continuing any compounded preparation
In addition, LCS3 (3 M, 96 h) can induce activation of ROS and NRF2 pathways in sensitive lung adenocarcinoma (LUAD) cells